Liver Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

  • Published : Jul-2017
  • Tables : 165
  • Figures : 51
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT73MR
  • Format : ppt

Liver cancer is the form of cancer wherein tissues of liver are affected by hepatitis B or hepatitis C virus. Cancer formed in the tissues of liver is termed as primary liver cancer, while the cancer which spreads to the liver from other parts of the body is known as secondary liver cancer.

Fact.MR, in its recent study, projects the global liver cancer diagnostics market to register a steady expansion at 5.5% CAGR during the forecast period 2017 to 2022. In 2017, the global market for liver cancer diagnostics is expected to reach nearly US$ 700 Mn in revenues.

Market Taxonomy

Test Type

End User

AFP Tests

Hospital Associated Labs

LFTs

Independent Diagnostic Laboratories

Biopsy

Cancer Research Institutes

Other

Others

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Prevalence of Liver Cancer to be reduced by Hepatitis Immunization and Lifestyle Modification

Liver cancer, the fifth most common cancer, accounted for 9.1% deaths among all cancer patients worldwide in 2012. Poor survival rate and extremely aggressive nature attributed to liver cancer has made this disease to become an imperative health issue around the world. Various risk factors have been associated with liver cancer, which include hepatitis B virus (HBV), exposure to dietary aflatoxin, alcohol-induced cirrhosis, diabetes, obesity, and infection associated with hepatitis C virus (HCV). As these risk factors are modifiable, a strong prospect has been offered for reducing its prevalence and mortality with the help of preventive strategies including hepatitis immunization and lifestyle modification.

Liver cancer, or, hepatocellular carcinoma (HCC) has been observed to cause a large number of deaths annually. In a bid to prevent liver cancer from reaching the final stage, scientists around the world have developed a slew of improved diagnostic solutions. Newer techniques are being developed for the diagnosis of hepatocellular carcinoma, rendering both partial hepatectomy, and liver transplant safer and more effective. Global leading medical instrument manufaturers are focusing on the development of new novel instruments in order to diagnose liver cancer completely. These factors are estimated to drive growth of the global liver cancer diagnostics market during the forecast period.

North America to Remain Dominant in the Global Liver Cancer Diagnostics Market

North America is expected to remain dominant in the global liver cancer diagnostics market, in terms of revenues. In addition, the markets for liver cancer diagnostics in North America and Europe are estimated to exhibit a parallel expansion at 5.6% CAGR through 2022. In contrast, markets in Japan and MEA are expected to exhibit a sluggish expansion during the forecast period.

Based on test type, biopsy test segment is expected to register the highest CAGR in the market through 2022, followed by LFTs. AFP test is estimated to remain preferred for liver cancer diagnostics in the global market. Revenue from AFP test is expected to account for over half share of the market in 2017, and is estimated to gain 52 BPS in its market share between 2017 and 2022.

Hospital-associated Labs to Remain Sought-after for Liver Cancer Diagnostics

Hospital-associated labs will continue to be sought-after for liver cancer diagnostics across the globe. Liver cancer diagnostics in hospital-associated labs will account for the largest revenues by 2022-end. Independent diagnostic laboratories will remain the second most lucrative end-users in the global liver cancer diagnostics market. In addition, liver cancer diagnostics in cancer research institutes are expected to register the fastest expansion over the forecast period.

Competition Tracking

The report has also profiled leading players in the global liver cancer diagnostics market, which include Illumina, Inc., Foundation Medicine, Inc., Danaher Corporation
Sysmex Corporation, and Biocept, Inc.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

1. Global Liver Cancer Diagnostics Market - Executive Summary

2. Global Liver Cancer Diagnostics Market Overview
2.1. Introduction
       2.1.1. Global Liver Cancer Diagnostics Market Taxonomy
       2.1.2. Global Liver Cancer Diagnostics Market Definition
2.2. Global Liver Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022
       2.2.1. Global Liver Cancer Diagnostics Market Y-o-Y Growth
2.3. Global Liver Cancer Diagnostics Market Dynamics
       2.3.1. Drivers
       2.3.2. Restraints
       2.3.3. Trends
2.4. Supply Chain
2.5. Epidemiology
2.6. List of Distributors
2.7. Average Pricing Analysis 
2.8. Regulations
2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Liver Cancer Diagnostics Market Analysis and Forecast By Test Type 
3.1. Global Liver Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022
       3.1.1. AFP Tests Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
                3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                3.1.1.2. Market Share Comparison, By Region
                3.1.1.3. Y-o-Y growth Comparison, By Region
       3.1.2. LFTs Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region
                3.1.2.2. Market Share Comparison, By Region
                3.1.2.3. Y-o-Y growth Comparison, By Region
       3.1.3. Biopsy Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
                3.1.3.1. Revenue (US$ Mn) Comparison, By Region
                3.1.3.2. Market Share Comparison, By Region
                3.1.3.3. Y-o-Y growth Comparison, By Region
       3.1.4. Other  Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
                3.1.4.1. Revenue (US$ Mn) Comparison, By Region
                3.1.4.2. Market Share Comparison, By Region
                3.1.4.3. Y-o-Y growth Comparison, By Region

4. Global Liver Cancer Diagnostics Market Analysis and Forecast By End User 
4.1. Global Liver Cancer Diagnostics Market Size and Forecast By End User, 2012-2022
       4.1.1. Hospital Associated Labs Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Independent Diagnostic Laboratories Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. Cancer Research Institutes Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                4.1.3.2. Market Share Comparison, By Region
                4.1.3.3. Y-o-Y growth Comparison, By Region
       4.1.4. Others Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
                4.1.4.1. Revenue (US$ Mn) Comparison, By Region
                4.1.4.2. Market Share Comparison, By Region
                4.1.4.3. Y-o-Y growth Comparison, By Region

5. Global Liver Cancer Diagnostics Market Analysis and Forecast By Region
5.1. Global Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       5.1.1. North America Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
                5.1.1.1. Revenue (US$ Mn) Comparison, By Test Type 
                5.1.1.2. Revenue (US$ Mn) Comparison, By End User 
       5.1.2. Latin America Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
                5.1.2.1. Revenue (US$ Mn) Comparison, By Test Type 
                5.1.2.2. Revenue (US$ Mn) Comparison, By End User 
       5.1.3. Europe Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
                5.1.3.1. Revenue (US$ Mn) Comparison, By Test Type 
                5.1.3.2. Revenue (US$ Mn) Comparison, By End User 
       5.1.4. Japan Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
                5.1.4.1. Revenue (US$ Mn) Comparison, By Test Type 
                5.1.4.2. Revenue (US$ Mn) Comparison, By End User 
       5.1.5. APEJ Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
                5.1.5.1. Revenue (US$ Mn) Comparison, By Test Type 
                5.1.5.2. Revenue (US$ Mn) Comparison, By End User 
       5.1.6. MEA Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
                5.1.6.1. Revenue (US$ Mn) Comparison, By Test Type 
                5.1.6.2. Revenue (US$ Mn) Comparison, By End User 

6. North America Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022
6.1. US Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       6.1.1. Revenue (US$ Mn) Comparison, By Test Type 
       6.1.2. Revenue (US$ Mn) Comparison, By End User 
6.2. Canada Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       6.2.1. Revenue (US$ Mn) Comparison, By Test Type 
       6.2.2. Revenue (US$ Mn) Comparison, By End User 

7. Latin America Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022
7.1. Brazil Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       7.1.1. Revenue (US$ Mn) Comparison, By Test Type 
       7.1.2. Revenue (US$ Mn) Comparison, By End User 
7.2. Mexico Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       7.2.1. Revenue (US$ Mn) Comparison, By Test Type 
       7.2.2. Revenue (US$ Mn) Comparison, By End User 
7.3. Argentina Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       7.3.1. Revenue (US$ Mn) Comparison, By Test Type 
       7.3.2. Revenue (US$ Mn) Comparison, By End User 

8. Europe Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022
8.1. Germany Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       8.1.1. Revenue (US$ Mn) Comparison, By Test Type 
       8.1.2. Revenue (US$ Mn) Comparison, By End User 
8.2. UK Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       8.2.1. Revenue (US$ Mn) Comparison, By Test Type 
       8.2.2. Revenue (US$ Mn) Comparison, By End User 
8.3. France Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       8.3.1. Revenue (US$ Mn) Comparison, By Test Type 
       8.3.2. Revenue (US$ Mn) Comparison, By End User 
8.4. Spain Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       8.4.1. Revenue (US$ Mn) Comparison, By Test Type 
       8.4.2. Revenue (US$ Mn) Comparison, By End User 
8.5. Italy Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       8.5.1. Revenue (US$ Mn) Comparison, By Test Type 
       8.5.2. Revenue (US$ Mn) Comparison, By End User 
8.6. Nordic Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       8.6.1. Revenue (US$ Mn) Comparison, By Test Type 
       8.6.2. Revenue (US$ Mn) Comparison, By End User 

9. Japan Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022
9.1. Japan  Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       9.1.1. Revenue (US$ Mn) Comparison, By Test Type 
       9.1.2. Revenue (US$ Mn) Comparison, By End User 

10. APEJ Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022
10.1. China Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       10.1.1. Revenue (US$ Mn) Comparison, By Test Type 
       10.1.2. Revenue (US$ Mn) Comparison, By End User 
10.2. India Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       10.2.1. Revenue (US$ Mn) Comparison, By Test Type 
       10.2.2. Revenue (US$ Mn) Comparison, By End User 
10.3. Malaysia Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       10.3.1. Revenue (US$ Mn) Comparison, By Test Type 
       10.3.2. Revenue (US$ Mn) Comparison, By End User 
10.4. Thailand Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       10.4.1. Revenue (US$ Mn) Comparison, By Test Type 
       10.4.2. Revenue (US$ Mn) Comparison, By End User 
10.5. Singapore Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       10.5.1. Revenue (US$ Mn) Comparison, By Test Type 
       10.5.2. Revenue (US$ Mn) Comparison, By End User 
10.6. Australia Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       10.6.1. Revenue (US$ Mn) Comparison, By Test Type 
       10.6.2. Revenue (US$ Mn) Comparison, By End User 

11. MEA Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022
11.1. GCC Countries Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       11.1.1. Revenue (US$ Mn) Comparison, By Test Type 
       11.1.2. Revenue (US$ Mn) Comparison, By End User 
11.2. South Africa Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       11.2.1. Revenue (US$ Mn) Comparison, By Test Type 
       11.2.2. Revenue (US$ Mn) Comparison, By End User 
11.3. Nigeria Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       11.3.1. Revenue (US$ Mn) Comparison, By Test Type 
       11.3.2. Revenue (US$ Mn) Comparison, By End User 
11.4. Israel Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
       11.4.1. Revenue (US$ Mn) Comparison, By Test Type 
       11.4.2. Revenue (US$ Mn) Comparison, By End User 

12. Global Liver Cancer Diagnostics Market Company/Manufactures/Distributors/Suppliers Profile and Revenue Projections
12.1. Company Share Analysis By Region
12.2. Abbott Laboratories
       12.2.1. Company Overview
       12.2.2. Liver Cancer Diagnostics Market Test Type list
       12.2.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials
       12.2.4. Key Developments
       12.2.5. SWOT Analysis
12.3. Agilent Technologies, Inc.
       12.3.1. Company Overview
       12.3.2. Liver Cancer Diagnostics Market Test Type list
       12.3.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials
       12.3.4. Key Developments
       12.3.5. SWOT Analysis
12.4. Bio Rad Laboratories Inc.
       12.4.1. Company Overview
       12.4.2. Liver Cancer Diagnostics Market Test Type list
       12.4.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials
       12.4.4. Key Developments
       12.4.5. SWOT Analysis
12.5. F. Hoffmann-La Roche Ltd.
       12.5.1. Company Overview
       12.5.2. Liver Cancer Diagnostics Market Test Type list
       12.5.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials
       12.5.4. Key Developments
       12.5.5. SWOT Analysis
12.6. Thermo Fisher Scientific Inc.
       12.6.1. Company Overview
       12.6.2. Liver Cancer Diagnostics Market Test Type list
       12.6.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials
       12.6.4. Key Developments
       12.6.5. SWOT Analysis
12.7. Magna International Inc. 
       12.7.1. Company Overview
       12.7.2. Liver Cancer Diagnostics Market Test Type list
       12.7.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials
       12.7.4. Key Developments
       12.7.5. SWOT Analysis
12.8. Hyundai Mobis 
       12.8.1. Company Overview
       12.8.2. Liver Cancer Diagnostics Market Test Type list
       12.8.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials
       12.8.4. Key Developments
       12.8.5. SWOT Analysis
12.9. Plastic Omnium Group 
       12.9.1. Company Overview
       12.9.2. Liver Cancer Diagnostics Market Test Type list
       12.9.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials
       12.9.4. Key Developments
       12.9.5. SWOT Analysis
12.10. Samvardhana Motherson Automotive Systems Group 
       12.10.1. Company Overview
       12.10.2. Liver Cancer Diagnostics Market Test Type list
       12.10.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials
       12.10.4. Key Developments
       12.10.5. SWOT Analysis
12.11. SL Corporation 
       12.11.1. Company Overview
       12.11.2. Liver Cancer Diagnostics Market Test Type list
       12.11.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials
       12.11.4. Key Developments
       12.11.5. SWOT Analysis
12.12. Valeo S.A. 
       12.12.1. Company Overview
       12.12.2. Liver Cancer Diagnostics Market Test Type list
       12.12.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials
       12.12.4. Key Developments
       12.12.5. SWOT Analysis
12.13. Montaplast GmbH
       12.13.1. Company Overview
       12.13.2. Liver Cancer Diagnostics Market Test Type list
       12.13.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials
       12.13.4. Key Developments
       12.13.5. SWOT Analysis

13. Research Methodology

14. Secondary and Primary Sources

15. Assumptions and Acronyms

16. Disclaimer

TABLE 1 Global Liver Cancer Diagnostics Market Value (US$ Mn), 2012-2016
TABLE 2 Global Liver Cancer Diagnostics Market Value (US$ Mn), 2017-2022
TABLE 3 Global Liver Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 4 Global AFP Tests Segment Value (US$ Mn), By Region 2012-2016
TABLE 5 Global AFP Tests Segment Value (US$ Mn), By Region 2017-2022
TABLE 6 Global AFP Tests Segment Market Share, By Region 2012-2016
TABLE 7 Global AFP Tests Segment Market Share, By Region 2017-2022
TABLE 8 Global AFP Tests Segment Y-o-Y, By Region 2015-2022
TABLE 9 Global LFTs Segment Value (US$ Mn), By Region 2012-2016
TABLE 10 Global LFTs Segment Value (US$ Mn), By Region 2017-2022
TABLE 11 Global LFTs Segment Market Share, By Region 2012-2016
TABLE 12 Global LFTs Segment Market Share, By Region 2017-2022
TABLE 13 Global LFTs Segment Y-o-Y, By Region 2015-2022
TABLE 14 Global Biopsy Segment Value (US$ Mn), By Region 2012-2016
TABLE 15 Global Biopsy Segment Value (US$ Mn), By Region 2017-2022
TABLE 16 Global Biopsy Segment Market Share, By Region 2012-2016
TABLE 17 Global Biopsy Segment Market Share, By Region 2017-2022
TABLE 18 Global Biopsy Segment Y-o-Y, By Region 2015-2022
TABLE 19 Global Other  Segment Value (US$ Mn), By Region 2012-2016
TABLE 20 Global Other  Segment Value (US$ Mn), By Region 2017-2022
TABLE 21 Global Other  Segment Market Share, By Region 2012-2016
TABLE 22 Global Other  Segment Market Share, By Region 2017-2022
TABLE 23 Global Other  Segment Y-o-Y, By Region 2015-2022
TABLE 24 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2012-2016
TABLE 25 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2017-2022
TABLE 26 Global Hospital Associated Labs Segment Market Share, By Region 2012-2016
TABLE 27 Global Hospital Associated Labs Segment Market Share, By Region 2017-2022
TABLE 28 Global Hospital Associated Labs Segment Y-o-Y, By Region 2015-2022
TABLE 29 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2012-2016
TABLE 30 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2017-2022
TABLE 31 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2012-2016
TABLE 32 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2017-2022
TABLE 33 Global Independent Diagnostic Laboratories Segment Y-o-Y, By Region 2015-2022
TABLE 34 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2012-2016
TABLE 35 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2017-2022
TABLE 36 Global Cancer Research Institutes Segment Market Share, By Region 2012-2016
TABLE 37 Global Cancer Research Institutes Segment Market Share, By Region 2017-2022
TABLE 38 Global Cancer Research Institutes Segment Y-o-Y, By Region 2015-2022
TABLE 39 Global Others Segment Value (US$ Mn), By Region 2012-2016
TABLE 40 Global Others Segment Value (US$ Mn), By Region 2017-2022
TABLE 41 Global Others Segment Market Share, By Region 2012-2016
TABLE 42 Global Others Segment Market Share, By Region 2017-2022
TABLE 43 Global Others Segment Y-o-Y, By Region 2015-2022
TABLE 44 North America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 45 North America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 46 North America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 47 North America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 48 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 49 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 50 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 51 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 52 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 53 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 54 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 55 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 56 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 57 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 58 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 59 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 60 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 61 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 62 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 63 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 64 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 65 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 66 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 67 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 68 US Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 69 US Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 70 US Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 71 US Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 72 Canada Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 73 Canada Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 74 Canada Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 75 Canada Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 76 Brazil Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 77 Brazil Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 78 Brazil Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 79 Brazil Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 80 Mexico Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 81 Mexico Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 82 Mexico Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 83 Mexico Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 84 Argentina Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 85 Argentina Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 86 Argentina Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 87 Argentina Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 88 Germany Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 89 Germany Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 90 Germany Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 91 Germany Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 92 UK Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 93 UK Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 94 UK Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 95 UK Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 96 France Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 97 France Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 98 France Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 99 France Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 100 Spain Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 101 Spain Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 102 Spain Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 103 Spain Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 104 Italy Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 105 Italy Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 106 Italy Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 107 Italy Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 108 Nordic Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 109 Nordic Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 110 Nordic Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 111 Nordic Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 112 Japan  Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 113 Japan  Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 114 Japan  Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 115 Japan  Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 116 China Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 117 China Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 118 China Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 119 China Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 120 India Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 121 India Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 122 India Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 123 India Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 124 Malaysia Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 125 Malaysia Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 126 Malaysia Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 127 Malaysia Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 128 Thailand Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 129 Thailand Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 130 Thailand Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 131 Thailand Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 132 Singapore Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 133 Singapore Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 134 Singapore Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 135 Singapore Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 136 Australia Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 137 Australia Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 138 Australia Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 139 Australia Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 140 GCC Countries Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 141 GCC Countries Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 142 GCC Countries Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 143 GCC Countries Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 144 South Africa Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 145 South Africa Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 146 South Africa Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 147 South Africa Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 148 Nigeria Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 149 Nigeria Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 150 Nigeria Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 151 Nigeria Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 152 Israel Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
TABLE 153 Israel Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
TABLE 154 Israel Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
TABLE 155 Israel Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
TABLE 156 Abbott Laboratories Value (US$ Mn), By Test Type 2017-2022
TABLE 157 Abbott Laboratories Value (US$ Mn), By End User 2017-2022
TABLE 158 Agilent Technologies, Inc. Value (US$ Mn), By Test Type 2017-2022
TABLE 159 Agilent Technologies, Inc. Value (US$ Mn), By End User 2017-2022
TABLE 160 Bio Rad Laboratories Inc. Value (US$ Mn), By Test Type 2017-2022
TABLE 161 Bio Rad Laboratories Inc. Value (US$ Mn), By End User 2017-2022
TABLE 162 F. Hoffmann-La Roche Ltd. Value (US$ Mn), By Test Type 2017-2022
TABLE 163 F. Hoffmann-La Roche Ltd. Value (US$ Mn), By End User 2017-2022
TABLE 164 Thermo Fisher Scientific Inc. Value (US$ Mn), By Test Type 2017-2022
TABLE 165 Thermo Fisher Scientific Inc. Value (US$ Mn), By End User 2017-2022

 

FIG. 1 Global Liver Cancer Diagnostics Market Value (US$ Mn), 2012-2016
FIG. 2 Global Liver Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2022
FIG. 3 Global Liver Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2022
FIG. 4 Global AFP Tests Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 5 Global AFP Tests Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 6 Global AFP Tests Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 7 Global LFTs Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 8 Global LFTs Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 9 Global LFTs Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 10 Global Biopsy Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 11 Global Biopsy Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 12 Global Biopsy Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 13 Global Other  Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 14 Global Other  Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 15 Global Other  Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 16 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 17 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 18 Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 19 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 20 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 21 Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 22 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 23 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 24 Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 25 Global Others Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 26 Global Others Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 27 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 28 North America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
FIG. 29 North America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
FIG. 30 North America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
FIG. 31 North America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
FIG. 32 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
FIG. 33 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
FIG. 34 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
FIG. 35 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
FIG. 36 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
FIG. 37 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
FIG. 38 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
FIG. 39 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
FIG. 40 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
FIG. 41 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
FIG. 42 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
FIG. 43 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
FIG. 44 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
FIG. 45 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
FIG. 46 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
FIG. 47 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022
FIG. 48 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016
FIG. 49 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022
FIG. 50 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016
FIG. 51 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022

 

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development